Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brian J. Karlovits"'
Autor:
Robert L. Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T. Ruffin, Carly Reeder, James Ohr, William E. Gooding, Seungwon Kim, Brian J. Karlovits, Dario A.A. Vignali, Umamaheswar Duvvuri, Jonas T. Johnson, Daniel Petro, Dwight E. Heron, David A. Clump, Tullia C. Bruno, Julie E. Bauman
Publikováno v:
Clin Cancer Res
Purpose: Concurrent radiotherapy with cetuximab, an anti-EGFR mAb, is a standard treatment for locally advanced head and neck squamous carcinoma (HNSCC). Cytotoxic T lymphocyte antigen-4–positive (CTLA-4+) regulatory T cells (Treg) dampen cellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8e0c45e8ea3a1fb53d59db2ef9ccb8
https://europepmc.org/articles/PMC9164766/
https://europepmc.org/articles/PMC9164766/
Autor:
Ahmad Mouhamad Wehbe, Seungwon Kim, Dwight E. Heron, Frank R. Miller, Athanassios Argiris, Malabika Sen, Sufi M. Thomas, Jennifer R. Grandis, Umamaheswar Duvvuri, Brian J Karlovits, David A. Clump, Julie E. Bauman, William E. Gooding
Publikováno v:
Cancer. 124:3881-3889
Background Cetuximab combined with radiation therapy (RT) is an evidence-based treatment for locally advanced head and neck squamous cell carcinoma (HNSCC); however, locoregional failure remains the primary cause of cancer-related death in this disea
Autor:
Joel S. Greenberger, Weijing Sun, Dwight E. Heron, Zachary D. Horne, James D. Luketich, Michael K. Gibson, Brian J Karlovits, Arjun Pennathur
Publikováno v:
Journal of Clinical Oncology. 35:160-160
160 Background: Treatment of T3-4/N+ esophageal cancer is challenging. Outcomes are suboptimal and patterns of care are not well defined for borderline-resectable esophageal cancer (BREC). We present our institutional experience using preoperative ch
Autor:
Dwight E. Heron, Jonas T. Johnson, U. Duvvuri, James Ohr, Brian J Karlovits, Daniel P. Petro, Julie E. Bauman, Sang Woo Kim, William E. Gooding, D.A. Clump, Robert L. Ferris
Publikováno v:
Annals of Oncology. 27:vi571
Autor:
Jennifer R. Grandis, Dwight E. Heron, Seungwon Kim, D.A. Clump, Athanassios Argiris, Jonas T. Johnson, Frank R. Miller, Robert L. Ferris, Ahmad Mouhamad Wehbe, Umamaheswar Duvvuri, Julie E. Bauman, William E. Gooding, James Ohr, Brian J Karlovits
Publikováno v:
Journal of Clinical Oncology. 33:6074-6074
6074 Background: Epidermal growth factor receptor (EGFR) is a validated therapeutic target in HNC. The combination of C-IMRT is a standard for locally advanced HNC; however, failure of locoregional control (LRC) remains the primary cause of cancer-re
Autor:
Dwight E. Heron, D.A. Clump, M.S. Huq, Steven A. Burton, Tianfang Li, Y Zhang, Xiang Li, Brian J Karlovits
Publikováno v:
Medical Physics. 41:199-199
Purpose: Lung stereo-tactic body radiotherapy(SBRT) treatment requires high accuracy of lung tumor positioning during treatment, which is usually accomplished by free breathing Cone-Beam computerized tomography (CBCT) scan. However, respiratory motio
Autor:
Seungwon Kim, Karen Holeva, Julie E. Bauman, William E. Gooding, Robert L. Ferris, Dwight E. Heron, Umamaheswar Duvvuri, James Ohr, D.A. Clump, Brian J Karlovits
Publikováno v:
Journal of Clinical Oncology. 32:TPS6104-TPS6104
TPS6104 Background: Concurrent therapy for PULA HNSCC using the EGFR-specific mAb cetuximab (C) plus IMRT is an accepted standard, however disease control in intermediate or high risk disease could...